Alexandre Boutet1,2, Robert Gramer2, Christopher J Steele3,4, Gavin J B Elias2, Jürgen Germann2, Ricardo Maciel2,5, Walter Kucharczyk1,2, Ludvic Zrinzo6, Andres M Lozano2, Alfonso Fasano7,8,9. 1. Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada. 2. University Health Network, Toronto, ON, Canada. 3. Department of Psychology, Concordia University, Montreal, Quebec, Canada. 4. Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany. 5. Division of Neurology, Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN University of Toronto, Toronto, Ontario, Canada. 6. Functional Neurosurgery Unit, Department of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, UK. 7. University Health Network, Toronto, ON, UK. alfonso.fasano@uhn.ca. 8. Krembil Brain Institute, Movement Disorders Centre - Toronto Western Hospital, 399 Bathurst St, 7McL410, Toronto, ON, M5T 2S8, Canada. alfonso.fasano@uhn.ca. 9. Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, ON, Canada. alfonso.fasano@uhn.ca.
Abstract
PURPOSE OF REVIEW: Ablations and particularly deep brain stimulation (DBS) of a variety of CNS targets are established therapeutic tools for movement disorders. Accurate targeting of the intended structure is crucial for optimal clinical outcomes. However, most targets used in functional neurosurgery are sub-optimally visualized on routine MRI. This article reviews recent neuroimaging advancements for targeting in movement disorders. RECENT FINDINGS: Dedicated MRI sequences can often visualize to some degree anatomical structures commonly targeted during DBS surgery, including at 1.5-T field strengths. Due to recent technological advancements, MR images using ultra-high magnetic field strengths and new acquisition parameters allow for markedly improved visualization of common movement disorder targets. In addition, novel neuroimaging techniques have enabled group-level analysis of DBS patients and delineation of areas associated with clinical benefits. These areas might diverge from the conventionally targeted nuclei and may instead correspond to white matter tracts or hubs of functional networks. Neuroimaging advancements have enabled improved direct visualization-based targeting as well as optimization and adjustment of conventionally targeted structures.
PURPOSE OF REVIEW: Ablations and particularly deep brain stimulation (DBS) of a variety of CNS targets are established therapeutic tools for movement disorders. Accurate targeting of the intended structure is crucial for optimal clinical outcomes. However, most targets used in functional neurosurgery are sub-optimally visualized on routine MRI. This article reviews recent neuroimaging advancements for targeting in movement disorders. RECENT FINDINGS: Dedicated MRI sequences can often visualize to some degree anatomical structures commonly targeted during DBS surgery, including at 1.5-T field strengths. Due to recent technological advancements, MR images using ultra-high magnetic field strengths and new acquisition parameters allow for markedly improved visualization of common movement disorder targets. In addition, novel neuroimaging techniques have enabled group-level analysis of DBS patients and delineation of areas associated with clinical benefits. These areas might diverge from the conventionally targeted nuclei and may instead correspond to white matter tracts or hubs of functional networks. Neuroimaging advancements have enabled improved direct visualization-based targeting as well as optimization and adjustment of conventionally targeted structures.
Entities:
Keywords:
Deep brain stimulation; Functional neurosurgery; MRI; Neuroimaging
Authors: Marwan I Hariz; Paul Krack; Roger Melvill; Jan V Jorgensen; Wolfgang Hamel; Hidehiro Hirabayashi; Mathieu Lenders; Nils Wesslen; Magnus Tengvar; Tarek A Yousry Journal: Stereotact Funct Neurosurg Date: 2003 Impact factor: 1.875
Authors: Srivatsan Pallavaram; Hong Yu; John Spooner; Pierre-François D'Haese; Bobby Bodenheimer; Peter E Konrad; Benoit M Dawant Journal: Stereotact Funct Neurosurg Date: 2008-02-13 Impact factor: 1.875
Authors: B P Bejjani; D Dormont; B Pidoux; J Yelnik; P Damier; I Arnulf; A M Bonnet; C Marsault; Y Agid; J Philippon; P Cornu Journal: J Neurosurg Date: 2000-04 Impact factor: 5.115
Authors: Heidi Johansen-Berg; Timothy E J Behrens; Emma Sillery; Olga Ciccarelli; Alan J Thompson; Stephen M Smith; Paul M Matthews Journal: Cereb Cortex Date: 2004-07-06 Impact factor: 5.357
Authors: Alexandre Boutet; Jurgen Germann; Dave Gwun; Aaron Loh; Gavin J B Elias; Clemens Neudorfer; Michelle Paff; Andreas Horn; Andrea A Kuhn; Renato P Munhoz; Suneil K Kalia; Mojgan Hodaie; Walter Kucharczyk; Alfonso Fasano; Andres M Lozano Journal: Brain Commun Date: 2021-03-10
Authors: Joachim K Krauss; Nir Lipsman; Tipu Aziz; Alexandre Boutet; Peter Brown; Jin Woo Chang; Benjamin Davidson; Warren M Grill; Marwan I Hariz; Andreas Horn; Michael Schulder; Antonios Mammis; Peter A Tass; Jens Volkmann; Andres M Lozano Journal: Nat Rev Neurol Date: 2020-11-26 Impact factor: 42.937